SEC filing record
Primary Source · SEC.gov

270 Healthcare Growth Fund I (LUX) SCSp-RAIF

Fund Vehicle2025 vintageRule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalFirst saleForm D/A · 2026-09-295 events: 1 first sale, 1 sold increased, 1 investors increasedLast filing 2026-09-29

Raised

$114M

Investors

18

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

270 Healthcare Growth Fund I (LUX) SCSp-RAIF is a Luxembourg entity organized in 2024 that first filed a Form D on September 29, 2025 and most recently amended it on September 29, 2026, describing itself as a private equity fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7) and covers equity and pooled investment fund interests. 270 Healthcare Growth Fund I (LUX) SCSp-RAIF reported $113,926,000 sold from 18 investors in an offering of indefinite size as of the Form D filed September 29, 2026. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing checks both Section 3(c)(1), which caps the fund at 100 beneficial owners, and Section 3(c)(7), which requires every investor to be a qualified purchaser, generally an individual with at least $5 million in investments. A fund normally relies on one or the other. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names J.P. Morgan Institutional Investments Inc. (CRD 102920), associated with None; J.P. Morgan Securities LLC (CRD 79), associated with None as recipients of sales compensation soliciting in all states. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 20, Rue De La Poste, Luxembourg, N4 L-2456.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002066084
Entity Name270 Healthcare Growth Fund I (LUX) SCSp-RAIF
ExemptionRule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners. Section 3(c)(7) of the Investment Company Act: the fund is excluded from investment-company registration because every investor is a qualified purchaser, generally an individual with at least $5 million in investments or an institution with at least $25 million.
Entity TypeOther
Jurisdiction of OrganizationLuxembourg
Year Organized2024
Issuer Address20, Rue De La Poste, Luxembourg, N4 L-2456
Phone(212) 464-1649
Industry / Fund TypePooled Investment Fund · Private Equity Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer) and Section 3(c)(7) (qualified purchasers only) (both boxes checked on the filing)
Securities TypeEquity, Pooled investment fund interests
First Sale DateSeptember 30, 2025
Filing DateSeptember 29, 2026
Accession Number0002066084-26-000001
Total Offering AmountIndefinite
Total Amount Sold$113,926,000
Amount Sold NoteCombined figure across related vehicles: The general partner of the Issuer reserves the right to offer a greater or lesser amount of limited partner interests. Total Offering Amount and Total Remaining to be Sold are aggregated with 270 Healthcare Growth Fund I LP.
Total Investors18
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationIntended to last more than one year
Sales Commissions$0 (to J.P. Morgan Institutional Investments Inc. and 1 other)
Finders' Fees$0
Proceeds to Related Persons$0
Revenue RangeDecline to Disclose
State (Issuer Address)N4
Amendment Count2 filings on record
Signed BySamantha Beattie, Executive Director of J.P. Morgan Investment Management Inc.

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

5

latest Sep 29, 2026

Critical / warning

0 / 0

3 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event First sale · Sep 29, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • The dated record: 1 fact with source, effective date and capture date, viewable as AltStreet knew them on any past day
  • 5 filing events with values and deltas, latest 2026-09-29, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Adviser of Record (Form ADV)

J.P. Morgan Investment Management INC.

CRD 107038 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a private equity fund

Auditor named on Form ADV: Pricewaterhousecoopers Assurance Société Coopérative · PCAOB-registered per the adviser

From the adviser's Form ADV as loaded from the SEC bulk data, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

270 Healthcare Growth Fund I GP (Lux) S.a r.l.

Director · LUXEMBOURG, N4

Gaurav Gupta

Executive Officer · New York, NY

Anya Schiess

Executive Officer · New York, NY

Patrick McGoldrick

Executive Officer · New York, NY

Samantha Beattie

Executive Officer · New York, NY

Stephen Squinto

Executive Officer · New York, NY

Joseph Siletto

Executive Officer · New York, NY

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

J.P. Morgan Institutional Investments Inc.CRD 102920 on BrokerCheck

Associated broker-dealer: None · New York, NY · Soliciting in all states

J.P. Morgan Securities LLCCRD 79 on BrokerCheck

Associated broker-dealer: None · New York, NY · Soliciting in all states

Questions About 270 Healthcare Growth Fund I (LUX) SCSp-RAIF

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is 270 Healthcare Growth Fund I (LUX) SCSp-RAIF?

270 Healthcare Growth Fund I (LUX) SCSp-RAIF is a Luxembourg entity organized in 2024 that filed a Form D with the SEC on September 29, 2026 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7) for an offering of equity and pooled investment fund interests.

Is 270 Healthcare Growth Fund I (LUX) SCSp-RAIF legit?

AltStreet does not rate legitimacy; it reports the public record. 270 Healthcare Growth Fund I (LUX) SCSp-RAIF filed a Form D with the SEC on September 29, 2026 claiming Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $113,926,000 sold to 18 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is 270 Healthcare Growth Fund I (LUX) SCSp-RAIF registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that 270 Healthcare Growth Fund I (LUX) SCSp-RAIF claimed Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has 270 Healthcare Growth Fund I (LUX) SCSp-RAIF raised?

270 Healthcare Growth Fund I (LUX) SCSp-RAIF reported $113,926,000 sold from 18 investors in an offering of indefinite size as of the Form D filed September 29, 2026. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone.

Who can invest in 270 Healthcare Growth Fund I (LUX) SCSp-RAIF?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing checks both Section 3(c)(1), which caps the fund at 100 beneficial owners, and Section 3(c)(7), which requires every investor to be a qualified purchaser, generally an individual with at least $5 million in investments. A fund normally relies on one or the other. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in 270 Healthcare Growth Fund I (LUX) SCSp-RAIF?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling 270 Healthcare Growth Fund I (LUX) SCSp-RAIF and how are they paid?

The Form D names J.P. Morgan Institutional Investments Inc. (CRD 102920), associated with None; J.P. Morgan Securities LLC (CRD 79), associated with None as recipients of sales compensation soliciting in all states. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind 270 Healthcare Growth Fund I (LUX) SCSp-RAIF?

The Form D lists 7 related persons: 270 Healthcare Growth Fund I GP (Lux) S.a r.l., director; Gaurav Gupta, executive officer; Anya Schiess, executive officer; Patrick McGoldrick, executive officer; Samantha Beattie, executive officer; Stephen Squinto, executive officer; Joseph Siletto, executive officer. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is 270 Healthcare Growth Fund I (LUX) SCSp-RAIF located?

The issuer's address on its SEC filings is 20, Rue De La Poste, Luxembourg, N4 L-2456. Its phone number of record is (212) 464-1649. It is organized under the laws of Luxembourg.

How long is the 270 Healthcare Growth Fund I (LUX) SCSp-RAIF offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.

How large is 270 Healthcare Growth Fund I (LUX) SCSp-RAIF?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.